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Levy et al' reviewed the incidence of bacterial meningitis in NSW and assessed the effectiveness of the notification system g Meningitis in ascertaining cases of meningitis.
surveillance 1991
We have reviewed meningitis again in NSW between July 1, 1990 and ___________________________ June 30, 1991 to: 99 
Maternal screening for
• I monitor trends in the incidence of bacterial meningitis; and Down's syndrome Incidence rates based on the ISC need to be interpreted with caution, as they arc likely to be under-estimates. True incidence rates require a full examination of individual hospital records, laboratory records and mortality data for deaths before admission. A study by Hanna' found that 60 per cent of children with a discharge diagnosis of ICD9-322.9 (meningitis, unspecified) did have bacterial meningitis (personal communication). We identified 191 cases with a discharge diagnosis of ICD9-322.9. The implication for NSW is that the true incidence of meningitis may be as high as 7.6/100,000 population. However, the strengths of the ISC for this type of review are that it is accessible, quick and inexpensive. Further, and most important, it provides valid results for monitoring trends. The detection of meningococcal meningitis by passive surveillance was disappointingly low, with only 19 per cent of cases detected compared to 54 pci-cent for the same period in 1990'.
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However, the first six months of 1991 coincided with the introduction of computer databases to PHUs and the low detection rate may reflect teething problems. Active surveillance fared better, detecting 89 per cent (34/38) of meningococcal meningitis and 72 per cent (130/180) of all bacterial meningitis identified by the ISC. The overall "ate D own's syndrome is the most common chromosomal disorder, with an incidence of about L2 per 1,000 births in Australia. It is characterised by mental retardation, hypotonia, prominent tongue, oblique palpebral fissures and epicanthic folds and is associated with congenital heart disease and strabismus. Down's syndrome can be diagnosed in pregnancy by chorionic villus sampling or amniocentesis. However, it is not feasible to apply these invasive procedures to all pregnant women. This article compares the impact in NSW of current screening practice and a proposed new test to identify women who are at increased risk of a Down's syndrome pregnancy.
The risk of a Down's syndrome pregnancy rises with increasing maternal age. This is the basis of current prenatal screening practice for Down's syndrome in NSW, whereby amniocentesis or chorionic villus sampling is offered to all women 37 years of age or oven But age alone is an unsatisfactory screen because the great majority of Down's syndrome pregnancies occur in younger women. A screening test which identifies high-risk pregnancies at all ages is needed. Four case-control studies'-4 and one prospective trial5 have shown that a combined screening test, which uses maternal age and three maternal serum markers (alpha-fetoprotein, uncor,jugated oestriol and human chorionic gonadotrophin) to calculate a woman's individual risk of having a Down's syndrome pregnancy, is better than maternal age alone.
SCREENING BY MATERNAL AGE ALONE
If the maternal age-specific incidence rates for Down's syndrome are applied to the distribution of maternal ages at birth in NSW during 1990 then 125 Down's syndrome babies would be expected to be born in that yean Of these, 35 (28 per cent) would occur in women aged 37 years and over, and 90 (72 per cent) in those aged less than 37 years. While the risk of Down's syndrome births is higher in the 37-plus age group, the majority of births are to women aged less than 37 years, and the majority of Down's syndrome births are also to women aged less than 37 years. The sensitivity of screening by maternal age alone is therefore 28 per cent (this assumes all eligible women agree to amniocentesis).
Of the 87,587 births in NSW during 1990 an estimated 4,586 (5 per cent) were to women aged 37 years or over. Only 35 of the infants born would be expected to have Down's syndrome. Thus, while the risk of Down's syndrome is higher in women aged 37-plus, most Down's syndromeaffected pregnancies occur in younger women, because the gi-eat majority of pregnancies occur in younger women. Screening by maternal age alone gives a false positive rate of 5 per cent, which may be expressed as a specificity of 95 per cent.
The amniocentesis rate in NSW for women aged 37 years and over is, in fact, about 50 per cent. Under the current screening program using maternal age alone, it is therefore expected that 17 (14 per cent) Down's syndrome pregnancies would be detected per year as a result of 2,293 amniocenteses and 108 (86 per cent) Down's syndrome pregnancies would be missed. Assuming a fetal loss rate of 0.5 per cent after amniocentesis, it is expected that about 11 normal fetuses will be lost. However, the sensitivity of the tiiple test increases and the specificity decreases with increasing maternal age ( Table 4) . The test is therefore better for detecting Down's syndrome pregnancy at older maternal ages, at the cost of a higher false positive rate.
The proportion of Down's syndrome pregnancies which is detected can be increased by reducing the risk cut-off level. But this will also increase the number of false positive results and the total number of amniocenteses. Table 5 shows the effect of raising or lowering the risk cut-off level for referral for amniocentesis for the NSW population.
It is unlikely that amniocentesis uptake rates will i-each 100 per cent. Figure 1 shows the effect of varying amniocentesis uptake rates on the number of Down's syndrome pregnancies detected and missed, and the number of fetuses lost (assuming a fetal loss rate due to amniocentesis of 0.5 per cent), at a risk cut-off level of 1:250. per cent or more, At the more likely amniocentesis uptake i-ate of 50 per cent more than twice the number of Down's syndrome pregnancies is missed than detected. Figure 2 shows the same information as Figure 1 but for a lower risk cut-off level of 1:350. This will increase the yield of Down's syndrome pregnancies to 84(67 per cent) -an increase of seven affected cases -for an increase in the number of amniocenteses by 1,934 to 6,390. The number of Down's syndrome cases affected will be greater than the number missed at amniocentesis uptake rates of 70 per cent or more. At the more likely uptake i-ate of 50 per cent, about twice as many Down's syndrome pregnancies will be missed as will be detected. However, at a fetal loss rate of 0.5 per cent due to amniocentesis, it is expected that 16 fetuses will be lost. It is therefore likely that a reduction in the risk cutoff to 1:350 will result in more additional fetuses lost than additional Down's syndrome pregnancies detected.
DISCUSSION
Mates-nal serum screening with the triple test yields about twice the number of Down's syndrome pregnancies as screening by maternal age alone, for a similar number of amniocenteses and a similar number of fetuses lost. A range of screening strategies is possible using maternal age or the triple test or a combination of both. detect an additional six Down's syndrome pregnancies as a result of an additional 4,177 amniocenteses. The combined strategy is not substantially better than triple test screening alone because the triple test already has maternal age incorporated into the algorithm.
The yield of Down's syndrome pregnancies detected may be increased in two ways. First, the risk cut-off level for the ti-iple test could be i-educed. This will probably result in the number of additional fetuses lost due to amniocentesis exceeding the number of additional Down's syndrome pregnancies detected. Second, the proportion of women who agree to amniocentesis could be increased. For example, in ordes-to detect 50 per cent of Down's syndrome pregnancies using triple test screening alone, an amniocentesis uptake rate of 82 per cent would be required, entailing 3,653 amniocenteses, equivalent to 4 per cent of the pregnant population. In order to detect 50 pci-cent of Down's syndrome pregnancies using a strategy which includes the offes of amniocentesis to all women aged 37-plus and triple test screening for the remainder, an amniocentesis uptake rate of 74 per cent would be required, entailing 6,457 amniocenteses, and equivalent to 7 pci-cent of the pregnant population.
Population-based maternal serum scl-eening for Down's syndrome using the triple test is the most efficient screening test available. A risk cut-off of 1:25 0 gives the best yield in terms of maximum Down's syndrome pregnancies detected foi the fewest number of amniocenteses. Howevel; even if all women who screen positive accept amniocentesis, only 61 per cent of Down's syndrome pregnancies will be detected. Triple test screening will also result in large numbers of false positive test results and some false negative results. Each mother screened will need to be carefully advised on the meaning of the test result, be it positive or negative. The result of an amniocentesis is known after about three weeks, and should be available by the 20th week of pregnancy so the family may decide whether to proceed with the pregnancy. Counselling services will need to be available almost immediately the test results are available, so a decision about amniocentesis can be reached and acted on promptly. For families living in rural regions, an amniocentesis will entail travel to a major centre at short notice.
The rate of some other chromosomal defects increases with increasing maternal age. These include trisomy 18, trisomy 13 and XXY abnormalities. Some trisomy 18 pregnancies have been detected after screening with the triple test, but the reliability of the test in regard to trisomy 18 is not known. If amniocentesis is offered only to women whose risk is high according to the triple test, regardless of maternal age, some affected pregnancies which would have been detected under screening based on maternal age will be missed. Obstet & Oynecol, 1991; 77(11:63.68. 5. Randall T (editorial) . Pregnancy Hormone Levels Signal Trisomy 21, Improved Screening, Lower Costs. JAM. 4, 1991; 266(141:1797-1798 . The editor is Dr George Rubin, Director, Epidemiology and Health Services Evaluation Branch, NSW Health Department. The Bulletin aims to preside its readers with population health data end information to motivate effective public health action. Articles, news and comments should be 1,000 werdo or leso in length and include the key points to be made in the first paragraph. Please submit items in hard copy and on diskette, preferably using WordPerfect 5.1. Please send to The Editor, Public Health Bulletin, Locked Mail Bag 951, North Sydney NSW 2059, Fax 02i 391 9232 Design -Health Public Affaii's Unit, NSW Health Department. Suggestions for improving the content arid foi-inat of the Bulletin are most welconie. Please contact your local Public Health Unit to obtain copies of the NSW Public Health Bulletin.
Lee Taylm Public Health Officeti Maternal and Child Health
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of detection was lowered in part by some PI-lUs actively seeking only cases of meningococcal meningitis. Table 3 shows that while most PHUs did not identiQy as many cases from their ArealRegion as the ISC, two PHUs identified more. Thei'e are several explanations for the discrepancies. Active surveillance, in some instances, was based on hospital admissions while the ISC reports separations so patients may have been admitted in the surveillance period but discharged after June 30, 1991 when the ISC closed. Also, patients may cross borders. In some cases more detail was provided on active surveillance. For example, a case identified to South Western Sydney PHU as meningococeal meningitis, on clinical grounds, was discharged as 'meningitis due to unspecified bacterium (ICD9-320.9)' because no organism was isolated. Finally, the ISC was not a full enumeration of all hospital separations for the study period. Full enumeration of all public hospital separations began on July 1, 1991 and will begin for all private hospital separations on July 1, 1993, which will alleviate this problem in the future.
Innovative changes to public health in NSW should assist passive surveillance of meningitis. The Public Health Act 1991 has made Hib meningitis a notifiable condition. It is to be notified by both hospitals and laboratories, which should not only increase detection rates but allow swift public health action to prevent secondary cases. This is also the case for meningococcal meningitis.
Another positive public health development has been the licensing of a first vaccine against Hib infections. Although immunisation for Hib infections will not be added to the childhood immunisation schedule until a vaccine that is suitable for children less than six months of age becomes avai1able a PRP-D vaccine is available on a retail basis for children aged 18 months. There has been a major improvement in the quality of infectious diseases data received from Public Health Units (PHTJs), both with respect to weekly reporting (Table 7) and the inclusion of basic epidemiological parameters on infectious disease notifications (Table 8 ).
RECOMMENDATION
-;] I * requires four injections of Triple Antigen, at the ages of two, four, six and 18 months.
NUMBER OF WEEKLY REPORTS MADE
To minimise the incidence of pertussis in the coming months, parents and medical attendants are urged to review the immunisation status of all children. Pertussis immunisation (Triple Antigen) can be given to any child under the age of four years.
The following public health measures should be taken if pertussis is diagnosed:
• Erythromycin should be given to cases to reduce transmission. • Unimmunised household contacts aged less than five years should be excluded from child-care facilities for 14 days after the last exposure to infection, or until they have received five days of a 14-day course of erythromycin.
The role of pertussis immunisation is enhancement of immunity before exposure. Pertussis vaccine does not prevent infection after exposure has occurred. 
INFLUENZA
MEASLES
Eighty-two per cent of notifications received in 1992 were for children over the age of one year. As measles immunisation is recommended at the age of 12 months, these cases were preventable by age-appropriate immunisation. 
TUBERCULOSIS
MENING0c0ccAL MENINGITIS
Three children died of meningococcal meningitis in AugustSeptember -a two-year-old male from North Coast Region, a four-year-old female in South Eastern Region and a threeyear-old male from the Hunter Area.
Notifications of meningococcal infections for the period January-August were 67 in 1991 and 58 in 1992, a decrease of 16 per cent. Notifications for meningococcal meningitis, for the same period, increased 37 per cent.
British and New Zealand Health Authorities have recently recommended that Benzylpenicillin should be cari-ied in doctors' emergency bags and administered to all suspected cases of meningococcal disease before transfer to hospital. This will not affect the ability to confirm a diagnosis, as bacterial antigen will be identifiable in the cerebrospinal fluid.
Children referred to hospitals with a differential diagnosis of meningitis should be triaged appropriately to prevent unnecessary delays in diagnosis.
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Infectious diseases -Continued from page 103
When meningitis is suspected in a child a lumbar puncture should be considered. No child should be discharged from hospital with a differential diagnosis of meningitis if a lumbar puncture has not been performed. One-third of the isolates were penicillin-resistant. Three per cent of strains showed a decreased sensitivity to quinolones. Tetracycline resistance has also been detected.
N0N-N0TIFIABLE SEXUALLY TRANSMuTED INFECTIONS
A specific gonococcal strain, fully sensitive to penicillin, continues to be isolated in increasing numbers since its first appearance in 1990. Isolations are almost exclusively from males. Although the majority of sites have been urethral, a relatively high proportion of specimens were rectal.
PuBLic HEALTH OFFICER OUTBREAK LOG
Since the inception of the training program in 1990 Public Health Officers (PHOs) have been closely involved in disease outbreak investigations throughout NSW, either as principal investigators or as part of an investigation team.
A disease outbreak log (Table 14) will be published periodically in the Public Health Bulletin. This will identify contact information for completed reports of disease investigations.
Copies of questionnaires used, correspondence, media communications and other field-tested procedural details may be made availabla 
HEPATITIS D
HUMAN IMMUNODEFICIENCY VIRUS
The pattern of risk factors for 1992 differs from that observed in the cumulative data set in several respects.
• In the cumulative data set, 54 per cent and 18 per cent of notifications respectively lack risk factor and sex information (Table 10 ). In the 1992 data, these have reduced to 39 per cent and 7 per cent respectively (Table 11 ).
•
The number of notifications associated with heterosexual exposure has increased from 5 per cent in the cumulative data (Table 10) to 12 per cent in the 1992 data (Thble 11) (these are percentages of the notifications for which risk factor data are available). Correspondingly, the proportion. of notifications specifying homosexual exposure has decreased slightly, from 86 per cent in the cumulative data (Table 10) to 82 per cent in the 1992 data (Table 11) . Quarantinable diseases include the viral haemorrhagic fevers (VHF) (Lassa fever; Ebola haemorrhagie fever, Marburg disease, Crimean-Congo haemorrhagic fever; Argentinian haemorrhagic fever; Bolivian haemorrhagic fever), cholera, plague, typhus (epidemic) and yellow fevei Westmead Hospital has been designated the preferred hospital for referral of patients within NSW with suspected VHFs.
In the development of a plan for the public health reponse and facilities for the clinical care and diagnosis of cases of VRFs in NSW four key elements need to be recognised:
A changing international perception of the degree of risk to health care workers by aerosol transmission of the viruses. The US Centers for Disease Control (C DC) recommend that levels of biological containment sufficient to restrict aerosol transmission must be used in the laboratory during diagnosis of these cases. Universal precautions must be followed at all times.
The rarity of patients presenting with VHFs in Australia (the last case was in 1987).
The clinical presentation may be non-specific (fever, pharyngitis, myalgia, haemorrhagic manifestations) and is likely to be mimicked by a more common condition. It is important to realise that the haemorrhagic manifestations occur late in the disease, and the clinical status is often labile.
Potential for severe illness requiring intensive care treatment.
Five possible forms of presentation can be envisaged: 1A case occurring on a ship or international flight en route to Sydney. Presentation 5 may require a single room in the intensive care unit. The likely frequency of this event is <1 in 10-20 years. Existing single rooms in the intensive care unit of major teaching hospitals could be used if they were modified. Duration of stay in the intensive care unit would depend on severity of illness, timing of diagnosis and response to antiviral agents (Ribavirin).
IMPLICATIONS FOR NSW HOSPiTALS
The Chief Health Officer has written to Chief Executive Officers and Regional Directors requesting that hospitals devise a local contingency plan for the management of patients with VHFs. Active involvement of infection control, nursing, laboratory and public health staff is encouraged.
All NSW hospitals should consider that a case of VHF could present as an inpatient or be referred to the Accident and Emergency Department by a medical practitioner. Each hospital is therefore required to have in place a contingency plan for the treatment and referral of patients with suspected VHFs, Planning of health resources for a very rare, but contagious and potentially fatal, disease, is very difficult, especially as advances in infection control, diagnosis and anti-viral treatment are to be expected in the next 10 years before such a case may occur. Whole structures of hospitals, including intensive care units, may be changed before one potential case emerges. It is important to plan for cases which might occur in the next month but realise that nothing may happen for five years. In these situations modifications of rooms, either low or high dependency, should be the mimimum required to comply with the CDC guidelines without impairing the normal day-to-day functioning of those rooms. is referred to any hospital in NSW for investigation, and VHF is recognised as a likely diagnosis, usually
The minimum requirement is an area that can be after exclusion of malaria and dengue. Improvement sealed off, with an adjoining anteroom. Ideally, an area may lead to discharge before definitive diagnosis. that can be sealed off, with an adjoining anteroom and a Failure to improve or deterioration would lead to separate degowning room on the exit side of the patient's transfer to Westmead Hospital.
room, needs to be identified in each hospital. There 5 Severely ill febrile patient with unsuspected VHF should be no movement from the patient's room to the anteroom (a clean area). Contingency plans for transfer in a hospital, or suspected when too ill to transfer to of patients to Westmead Hospital need to be devised. But Westmead.
it must be realised that patients with suspected V}TFs The most likely presentation is the second. Thin/thick present a diagnostic dilemma, and are clinically labile, films for malaria may provide a diagnosis but dual so immediate transfer may not always be possible. infections have been recorded.
NEWS AND COMMENT WORKCOVER AUTHORISED MEDICAL PRACTiTIONER NETWORK
T he Occupational Medicine Branch of the NSW WorkC over Authority ensures the provision of a wide range of occupational medicine services to workers in NSW This is achieved in conjunction with medical practitioners authorised by WorkCover to conduct certain statutory medical examinations. This network of medical practitioners numbers more than 360 and includes general practitioners and specialists including occupational physicians and academics. WorkC over aims to expand the network so all workers in NSW have ready access to medical advice on occupational health matters. The network has the potential to deliver a wide range of occupational medical services at the local level, and also serves as a model for the development of a national approach to providing effective occupational health services, particularly in rural areas. Workers requiring medical examination under current regulations include those engaged in the asbestos, abrasive blasting, electroplating, lead, spray painting and pest control industries.
Available WorkCover medical training
Since the introduction of the Occupational Health and Safety Act in 1983 there has been an upsurge of interest in occupational health in the general community. In turn, medical practitioners have been increasingly approached by employers and employees to provide occupationally related medical services. To support these practitioners a training program has been developed by the Occupational Medicine Branch of WorkCover. This activity was formalised in 1987 with the introduction of an induction seminar for all new WorkC over Authorised Medical Practitioners. The seminar has been repeated twice yearly since then and has been extended from a half-day to a two-day program. Each participant is given a training manual which can be kept for reference. The depth of learning is up to each participant, but literature references are given in the training manual so topics of interest or controversy may be explored furthen The occupational physicians of WorkCover are also available for further discussion. A takehome multiple choice examination is also given to reinforce the learning of important concepts. After successful completion of the examination the medical practitioners enter the WorkCover Authorised Medical Practitioner Network where they receive support fi-om WorkCover occupational health physicians. Workilover aims not only to improve the standard of occupational statutory medical examinations but to encourage medical practitioners to go further and develop their skills in occupational medicine.
Provision is made in this proposed regulation for the occupational medical examination of workers by WorkCover Authorised Medical Practitioners. In recognition of the fact that these practitioners have received training in the health effects of hazardous substances, the exact form of the medical examination is usually left to the judgment of the practitioner. This approach ensures flexibility in matching the medical examination to the individual worker's needs. It also encourages a rational approach to the investigation of new health hazards due to changes in workplace technology. The Authorised Medical Practitioner is responsible for coordinating occupational health surveillance, performing medical examinations and determining workrelated health effects.
In response to these developments the induction seminar is being developed further to incorporate a general approach to the management of workers exposed to hazardous chemicals and dusts. Sources of information on the extremely wide range of hazardous substances in use will be given. More specifically, the health issues surrounding the use of potential or proven carcinogenic substances in the workplace will be addressed. Other issues to be covered include the risks associated with occupational exposure to synthetic mineral fibres and chemicals affecting reproduction. 
CONFERENCE REMINDER
The first annual NSW Public Health Network Conference will be held on November 23 and 24 at Westmead Hospital. The main speakers will include Professor Peter Baume, Ms Liz Williams, Dr Lyn Clarke and Professor Phillip Boyce. NSW Health Department Director-General Dr Bernie Amos will open the conference, which aims to present the scientific activities of members of the Public Health Network. Sessions will cover environmental health, infectious disease, chronic disease and injury, health services and economics, and maternal and child health.
Registration fee is $60 for the two days, or $30 a day. Registration forms can be obtained by contacting the conference organiser by telephone (02) 391 9218 or facsimile (02) 391 9232.
Ievelopments for the control of hazardous substances
The training program had been restricted to some extent by the specific nature of current regulations. Howevei it is government policy to review and to rationalise regulations. In the area of hazardous substances, this means the replacement of a large number of relatively specific regulations with just one regulation. The proposed Hazardous Substances Regulation has recently received public comment and is expected to be gazetted by mid-1993. This regulation is designed to cover the use and safe handling of a wide range of hazardous chemicals and dusts.
CALLING CENTRAL COAST PHU
The facsimile number shown in the May 1992 Public Health Bulletin for the Central Coast Public Health Unit was incorrect. The number shown was that of the Central Coast Area Health Service (general number).
The correct facsimile number for the Central Coast PHU is (04) 202822.
